Follow
Kalyan Immadisetty
Title
Cited by
Cited by
Year
Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients
M Ono, DE Burgess, EA Schroder, CS Elayi, CL Anderson, CT January, ...
Biomolecules 10 (8), 1144, 2020
352020
Lipid-dependent alternating access mechanism of a bacterial multidrug ABC exporter
K Immadisetty, J Hettige, M Moradi
ACS Central Science 5 (1), 43-56, 2019
312019
New design strategies for antidepressant drugs
K Immadisetty, LM Geffert, CK Surratt, JD Madura
Expert opinion on drug discovery 8 (11), 1399-1414, 2013
312013
What can and cannot be learned from molecular dynamics simulations of bacterial proton-coupled oligopeptide transporter GkPOT?
K Immadisetty, J Hettige, M Moradi
The Journal of Physical Chemistry B 121 (15), 3644-3656, 2017
282017
Pathogenic variants in TNNC2 cause congenital myopathy due to an impaired force response to calcium
M van de Locht, S Donkervoort, JM de Winter, S Conijn, L Begthel, ...
The Journal of clinical investigation 131 (9), 2021
19*2021
A review of monoamine transporter-ligand interactions
K Immadisetty, J D Madura
Current computer-aided drug design 9 (4), 556-568, 2013
182013
The role of a crystallographically unresolved cytoplasmic loop in stabilizing the bacterial membrane insertase yidc2
T Harkey, V Govind Kumar, J Hettige, SH Tabari, K Immadisetty, M Moradi
Scientific reports 9 (1), 14451, 2019
132019
Structural changes beyond the ef-hand contribute to apparent calcium binding affinities: Insights from parvalbumins
K Immadisetty, B Sun, PM Kekenes-Huskey
The Journal of Physical Chemistry B 125 (24), 6390-6405, 2021
112021
An investigation of the YidC-mediated membrane insertion of Pf3 coat protein using molecular dynamics simulations
A Polasa, JJ Hettige, K Immadisetty, M Moradi
Frontiers in Molecular Biosciences, 2022
7*2022
Elucidating the molecular basis of spontaneous activation in an engineered mechanosensitive channel
K Immadisetty, A Polasa, R Shelton, M Moradi
Computational and Structural Biotechnology Journal 20, 2539-2550, 2022
7*2022
Modulation of P2X4 pore closure by magnesium, potassium, and ATP
K Immadisetty, J Alenciks, PM Kekenes-Huskey
Biophysical Journal 121 (7), 1134-1142, 2022
62022
Mechanistic Picture for Chemomechanical Coupling in a Bacterial Proton-Coupled Oligopeptide Transporter from Streptococcus Thermophilus
K Immadisetty, M Moradi
The Journal of Physical Chemistry B, 2021
42021
Recent breakthroughs in computational structural biology harnessing the power of sequences and structures
B Mészáros, E Park, D Malinverni, BI Sejdiu, K Immadisetty, M Sandhu, ...
Current Opinion in Structural Biology 80, 102608, 2023
32023
Conformational Transition Pathways in Major Facilitator Superfamily Transporters
D Ogden, K Immadisetty, M Moradi
bioRxiv, 708289, 2019
32019
Prediction of Kv11. 1 potassium channel PAS-domain variants trafficking via machine learning
K Immadisetty, X Fang, G San Ramon, CM Hartle, TP McCoy, RG Center, ...
Journal of Molecular and Cellular Cardiology 180, 69-83, 2023
22023
Modeling the binding of inhibitors/drugs to the human serotonin transporter
K Immadisetty
12015
Pathogenic TNNI1 variants disrupt sarcomere contractility resulting in hypo- and hypercontractile muscle disease
S Donkervoort, M van de Locht, D Ronchi, J Reunert, CA McLean, M Zaki, ...
Science Translational Medicine 16 (741), eadg2841, 2024
2024
Peptide-scFv antigen recognition domains effectively confer CAR T cell multiantigen specificity
JT Zoine, K Immadisetty, J Ibanez-Vega, SE Moore, C Nevitt, U Thanekar, ...
Cell Reports Medicine, 2024
2024
Importance of AB domain in parvalbumins’ calcium binding affinity
K Immadisetty, J Jacob-Dolan
bioRxiv, 2022.05. 27.493786, 2022
2022
Prediction of hERG potassium channel PAS-domain variants trafficking via machine learning
K Immadisetty, PM Kekenes-Huskey
Biorxiv, 2021.11. 03.467212, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20